| Issuer: | Acerus Pharmaceuticals Corporation |
| Securities: | Common Shares (the "Securities") |
| Symbol(s): | ASP |
| Delisting Date: | March 3, 2023 (at the close) |
| Reason: | Failure to meet continued listing requirements. |
| Trading Status: | The Securities will remain suspended from trading. |
| Additional Information: | TSX Bulletin 2023-0057 dated January 26, 2023. |
| TSX contact: | Selma Thaver, Director, TSX Listings |
TMX Group Limited and its affiliates do not endorse or recommend any securities issued by any companies identified on, or linked through, this site. Please seek professional advice to evaluate specific securities or other content on this site. All content (including any links to third party sites) is provided for informational purposes only (and not for trading purposes), and is not intended to provide legal, accounting, tax, investment, financial or other advice and should not be relied upon for such advice. The views, opinions and advice of any third party reflect those of the individual authors and are not endorsed by TMX Group Limited or its affiliates. TMX Group Limited and its affiliates have not prepared, reviewed or updated the content of third parties on this site or the content of any third party sites, and assume no responsibility for such information.
